Table 1.
Patient characteristics
| total n | % | PET_CT stage III (n, %) | PET_CT stage IV by SdLNM (n, %) | PET_CT stage IV by other (n, %) | p-value | ||||
|---|---|---|---|---|---|---|---|---|---|
| median Age (years, IQR) | 176 | 100 | 108 | 55.9 | 40 | 22.4 | 28 | 19.7 | 0.627 |
| 55 (48–63) | 54 (47–63) | 55 (49–63) | 55 (48–60) | ||||||
| median initial CA-125 (U/mL, IQR) | 848.05 (334.97–2387.32) | 659.35 (296.20–2446.90) | 1111.80 (712.0–2483.15) | 1048.15 (148.45–2111.65) | 0.130 | ||||
| FIGO stage | |||||||||
| IIIB | 11 | 6.3 | 8 | 7.4 | 3 | 7.5 | 0 | 0.0 | |
| IIIC | 100 | 56.8 | 76 | 70.4 | 13 | 32.5 | 11 | 39.3 | |
| IVA | 4 | 2.3 | 3 | 2.8 | 1 | 2.5 | 0 | 0.0 | |
| IVB | 61 | 34.7 | 21 | 19.4 | 23 | 57.5 | 17 | 60.7 | 0.502 |
| Histology | |||||||||
| high grade serous | 136 | 77.3 | 82 | 75.9 | 34 | 85.0 | 20 | 71.4 | |
| others | 40 | 22.7 | 26 | 24.1 | 6 | 15.0 | 8 | 28.6 | 0.423 |
| Grade | |||||||||
| 1 | 14 | 8.0 | 10 | 9.3 | 2 | 5.0 | 2 | 7.1 | |
| 2 | 59 | 33.5 | 38 | 35.2 | 13 | 32.5 | 8 | 28.6 | |
| 3 | 88 | 50.0 | 50 | 46.3 | 23 | 57.5 | 15 | 53.6 | 0.122 |
| unknown | 15 | 8.5 | 0.0 | 0.0 | 0.0 | ||||
| Residual disease (NGR vs other) | |||||||||
| NGR | 38 | 25.9 | 23 | 26.1 | 10 | 27.8 | 5 | 21.7 | |
| any residuals | 109 | 74.1 | 65 | 72.2 | 26 | 72.2 | 18 | 78.3 | 0.804 |
| unknown | 29 | 20 | 4 | 5 | |||||
NGR No gross residual disease